Literature DB >> 24890088

Rupture of an extended mycotic aneurysm of the descending thoracic aorta in a multiple myeloma patient undergoing anti-myeloma therapy.

Akira Marumoto1, Keiji Iwata2.   

Abstract

Infectious complications in patients with multiple myeloma remain the main cause of mortality because of disease-related immunodeficiency. A mycotic aortic aneurysm caused by Burkhoderia cepacia, which has been recognized as nosocomial pathogen in immunocompromised populations, is very rare and only few cases have been reported in the literature. We describe an unusual case of a ruptured mycotic aneurysm of the descending thoracic aorta with a DeBakey IIIb aortic dissection caused by Burkhoderia cepacia in a patient with active multiple myeloma during chemotherapy with anti-myeloma agents. Successful treatment of this mycotic aneurysm included appropriate antibiotic therapy and replacement of the aortic arch and the descending aorta for the extensive debridement of all infected aortas. This was followed by the wrapping of a prosthetic graft with a well-vascularized tissue flap of the greater omentum and of the latissimus dorsi muscle.

Entities:  

Keywords:  Immunocompromised patient; Multiple myeloma; Mycotic aneurysm

Mesh:

Substances:

Year:  2014        PMID: 24890088     DOI: 10.1007/s11748-014-0415-9

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  11 in total

1.  Recurrent rupture of an infected aortic arch.

Authors:  Tadashi Kitamura; Robert G Stuklis; John Stubberfield; James Edwards
Journal:  Tex Heart Inst J       Date:  2010

2.  En bloc resection and extended replacement of the infected aortic arch.

Authors:  Toshinori Totsugawa; Hiroki Takiuchi; Masahiko Kuinose; Hidenori Yoshitaka; Yoshimasa Tsushima; Atsuhisa Ishida
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-06-15

3.  Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party.

Authors:  Bradley M Augustson; Gulnaz Begum; Janet A Dunn; Nicola J Barth; Faith Davies; Gareth Morgan; Judith Behrens; Alastair Smith; J Anthony Child; Mark T Drayson
Journal:  J Clin Oncol       Date:  2005-11-07       Impact factor: 44.544

4.  Treatment of postoperative infection of ascending aorta and transverse aortic arch, including use of viable omentum and muscle flaps.

Authors:  J S Coselli; E S Crawford; T W Williams; M W Bradshaw; D R Wiemer; R L Harris; H J Safi
Journal:  Ann Thorac Surg       Date:  1990-12       Impact factor: 4.330

5.  A case of native valve endocarditis caused by Burkholderia cepacia without predisposing factors.

Authors:  Hyun Kyun Ki; Sung Hea Kim; Seong Woo Han; Hae Suk Cheong
Journal:  BMC Infect Dis       Date:  2011-05-08       Impact factor: 3.090

6.  Bacterial diversity in aortic aneurysms determined by 16S ribosomal RNA gene analysis.

Authors:  Rafael Marques da Silva; Dominique A Caugant; Emenike R K Eribe; Jørn A Aas; Per S Lingaas; Odd Geiran; Leif Tronstad; Ingar Olsen
Journal:  J Vasc Surg       Date:  2006-11       Impact factor: 4.268

Review 7.  Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents.

Authors:  Marcio Nucci; Elias Anaissie
Journal:  Clin Infect Dis       Date:  2009-10-15       Impact factor: 9.079

8.  Surgery for infected aneurysm of the aortic arch.

Authors:  Ron-Bin Hsu; Fang-Yue Lin
Journal:  J Thorac Cardiovasc Surg       Date:  2007-11       Impact factor: 5.209

Review 9.  Outcome after endovascular stent graft treatment for mycotic aortic aneurysm: a systematic review.

Authors:  Chung-Dann Kan; Hsin-Ling Lee; Yu-Jen Yang
Journal:  J Vasc Surg       Date:  2007-10-01       Impact factor: 4.268

Review 10.  Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis.

Authors:  Laura A Porter; Joanna B Goldberg
Journal:  Front Cell Infect Microbiol       Date:  2011-11-18       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.